Literature DB >> 23649099

Plasma volume expansion by 0.9% NaCl during sepsis/systemic inflammatory response syndrome, after hemorrhage, and during a normal state.

Björn P Bark1, Carl M Öberg, Per-Olof Grände.   

Abstract

OBJECTIVE: The objective of this study was to determine the degree of plasma volume expansion by 0.9% NaCl in relation to the infused volume, in sepsis/systemic inflammatory response syndrome (SIRS), after a standardized hemorrhage, and in a normal condition.
DESIGN: Prospective, randomized animal study.
SETTING: The study was performed at a university hospital laboratory.
SUBJECTS: Thirty anesthetized adult male rats were included in the study.
INTERVENTIONS: The study was performed in three groups: a sepsis/SIRS group (the S group), in which sepsis/SIRS was induced by cecal ligation and incision; a hemorrhage group (the H group), in which the rats were left without intervention for 4 h and bled 8 mL/kg thereafter; and a group that was left without intervention (the N group). Then, 4 h after baseline, all three groups were given an infusion of 0.9% NaCl (32 mL/kg) for 15 min. Baseline was defined as the time point when the surgical preparation was finished.
MEASUREMENTS AND MAIN RESULTS: Plasma volumes were measured using I-albumin dilution technique at baseline, after 4 h, and 20 min after the end of infusion. The plasma volume-expanding effect 20 min after end of infusion was 0.6% ± 2.9% in the S group, 20% ± 6.4% in the H group, and 12% ± 11% in the N group, compared with just before start of infusion.
CONCLUSIONS: The present study in rats showed that the plasma volume-expanding effect after an infusion of 0.9% NaCl was smaller in a septic/SIRS state than after hemorrhage and in a normal state. This indicates that the plasma volume-expanding effect of a crystalloid is dependent on pathophysiologic changes in sepsis/SIRS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649099     DOI: 10.1097/SHK.0b013e3182986a62

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Response to fluid boluses in the fluid and catheter treatment trial.

Authors:  Matthew R Lammi; Brianne Aiello; Gregory T Burg; Tayyab Rehman; Ivor S Douglas; Arthur P Wheeler; Bennett P deBoisblanc
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

2.  Beyond the fluid bolus.

Authors:  Peter Bentzer; Anja Lindén-Søndersø
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 3.  Predicting the Need for Fluid Therapy-Does Fluid Responsiveness Work?

Authors:  Hiroshi Ueyama; Sawami Kiyonaka
Journal:  J Intensive Care       Date:  2017-06-06

Review 4.  Fluid resuscitation in human sepsis: Time to rewrite history?

Authors:  Liam Byrne; Frank Van Haren
Journal:  Ann Intensive Care       Date:  2017-01-03       Impact factor: 6.925

Review 5.  Intravenous Fluid Administration and the Coagulation System.

Authors:  Corrin J Boyd; Benjamin M Brainard; Lisa Smart
Journal:  Front Vet Sci       Date:  2021-04-15

6.  A novel Vascular Leak Index identifies sepsis patients with a higher risk for in-hospital death and fluid accumulation.

Authors:  Jay Chandra; Miguel A Armengol de la Hoz; Gwendolyn Lee; Alexandria Lee; Patrick Thoral; Paul Elbers; Hyung-Chul Lee; John S Munger; Leo Anthony Celi; David A Kaufman
Journal:  Crit Care       Date:  2022-04-11       Impact factor: 9.097

7.  Effect of ringers acetate in different doses on plasma volume in rat models of hypovolemia.

Authors:  Svajunas Statkevicius; Attila Frigyesi; Peter Bentzer
Journal:  Intensive Care Med Exp       Date:  2017-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.